124 related articles for article (PubMed ID: 32041444)
1. Association of Circulating Osteopontin Levels With Lower Extremity Arterial Disease in Subjects With Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study.
Eleftheriadou I; Tsilingiris D; Tentolouris A; Mourouzis I; Grigoropoulou P; Kapelios C; Pantos C; Makrilakis K; Tentolouris N
Int J Low Extrem Wounds; 2020 Jun; 19(2):180-189. PubMed ID: 32041444
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus.
Yan X; Sano M; Lu L; Wang W; Zhang Q; Zhang R; Wang L; Chen Q; Fukuda K; Shen W
Cardiovasc Diabetol; 2010 Oct; 9():70. PubMed ID: 21034455
[TBL] [Abstract][Full Text] [Related]
4. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.
Barchetta I; Ceccarelli V; Cimini FA; Bertoccini L; Fraioli A; Alessandri C; Lenzi A; Baroni MG; Cavallo MG
J Endocrinol Invest; 2019 May; 42(5):513-520. PubMed ID: 30132286
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wang C; He M; Peng J; Li S; Long M; Chen W; Liu D; Yang G; Zhang L
Cytokine; 2020 Jan; 125():154837. PubMed ID: 31514105
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function.
Maser RE; James Lenhard M; Pohlig RT; Babu Balagopal P
Neurol Sci; 2017 Sep; 38(9):1645-1650. PubMed ID: 28638999
[TBL] [Abstract][Full Text] [Related]
7. Association between bone metabolism regulators and arterial stiffness in type 2 diabetes patients.
Sharif S; Bots ML; Schalkwijk C; Stehouwer CDA; Visseren FLJ; Westerink J;
Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1245-1252. PubMed ID: 30017437
[TBL] [Abstract][Full Text] [Related]
8. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
Berezin AE; Kremzer AA
Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
[TBL] [Abstract][Full Text] [Related]
9. The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus.
Eleftheriadou I; Tentolouris A; Grigoropoulou P; Tsilingiris D; Anastasiou I; Kokkinos A; Perrea D; Katsilambros N; Tentolouris N
J Diabetes Complications; 2019 Feb; 33(2):165-170. PubMed ID: 30446479
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with sclerostin levels - A calcification inhibitor - In individuals with type 2 diabetes mellitus; Is autonomic neuropathy the missing link?
Eleftheriadou I; Tentolouris A; Anastasiou IA; Mourouzis I; Tsilingiris D; Kosta O; Grigoropoulou P; Tentolouris N
J Diabetes Complications; 2020 Oct; 34(10):107677. PubMed ID: 32713708
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of osteopontin predict diabetes remission after bariatric surgery.
Carbone F; Adami G; Liberale L; Bonaventura A; Bertolotto M; Andraghetti G; Scopinaro N; Camerini GB; Papadia FS; Cordera R; Dallegri F; Montecucco F
Diabetes Metab; 2019 Sep; 45(4):356-362. PubMed ID: 30268840
[TBL] [Abstract][Full Text] [Related]
12. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function.
Maser RE; Lenhard MJ; Pohlig RT; Balagopal PB
J Diabetes Complications; 2016 Apr; 30(3):507-10. PubMed ID: 26775555
[TBL] [Abstract][Full Text] [Related]
14. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma osteopontin with diabetic retinopathy in Asians with type 2 diabetes.
Zhang X; Chee WK; Liu S; Tavintharan S; Sum CF; Lim SC; Kumari N
Mol Vis; 2018; 24():165-173. PubMed ID: 29463954
[TBL] [Abstract][Full Text] [Related]
16. Correlation Analysis between Serum Vitamin D Levels and Lower Extremity Macrovascular Complications in Individuals with Type 2 Diabetes Mellitus.
Yang M; Liu J; Zhou X; Ding H; Xu J; Yang B; Sun B; Xiao D; Yu J; Gong Q
J Diabetes Res; 2019; 2019():4251829. PubMed ID: 31871946
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.
He X; Hu X; Ma X; Su H; Ying L; Peng J; Pan X; Bao Y; Zhou J; Jia W
Cardiovasc Diabetol; 2017 Jun; 16(1):77. PubMed ID: 28619026
[TBL] [Abstract][Full Text] [Related]
18. Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes.
Li J; Li Y; Ma W; Liu Y; Yin X; Xie C; Bai J; Zhang M
Diabetes Metab Syndr; 2020; 14(6):2081-2085. PubMed ID: 33137566
[TBL] [Abstract][Full Text] [Related]
19. Association of sudomotor function with peripheral artery disease in type 2 diabetes.
Chahal S; Vohra K; Syngle A
Neurol Sci; 2017 Jan; 38(1):151-156. PubMed ID: 27783183
[TBL] [Abstract][Full Text] [Related]
20. Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients.
Yamaguchi H; Igarashi M; Hirata A; Tsuchiya H; Sugiyama K; Morita Y; Jimbu Y; Ohnuma H; Daimon M; Tominaga M; Kato T
Endocr J; 2004 Oct; 51(5):499-504. PubMed ID: 15516785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
